GL1X · GenesisL1 explorer

Research workbench

Crystal structure of calcium binding domain of CPCDPK3, CGD5_820

Analyse Crystal structure of calcium binding domain of CPCDPK3, CGD5_820 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3L19
Type
protein
Length
363 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
CALCIUM/CALMODULIN dependent protein kinase with a kinase domain and 4 calmodulin like ef…
EC
2.7.1.-
UniProt
Q5CS01
Ligands
CA
Pockets
4 · best druggability 0.49

Structure

x-ray diffraction · 2 distinct chains · 64% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACALCIUM/CALMODULIN dependent protein kinase with a kinase domain and 4 calmodulin like ef hands (EC 2.7.1.-)protein18464% helix, 4% strandQ5CS01
BCALCIUM/CALMODULIN dependent protein kinase with a kinase domain and 4 calmodulin like ef hands (EC 2.7.1.-)protein17964% helix, 4% strandQ5CS01

Ligands and binding sites

  • CA · Calcium ion · metal · 8 copies · chains A, B
  • GOL · Glycerol · additive · 4 copies · chains A, B
  • 1PE · Pentaethylene glycol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11900.490.7631GOL, 1PE
21430.410.7423empty
3910.330.7316empty
4630.290.7417empty

Interfaces

1 interface between chains.

  • A–B · 410 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • 3L19 · Crystal structure of calcium binding domain of CpCDPK3, cgd5_820 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.